NeuroMetrix Granted European Patent Number EP3538202 Titled "'ranscutaneous Electrical Nerve Stimulation Using Novel Unbalanced Biphasic Waveform And Novel Electrode Arrangement'
Portfolio Pulse from Benzinga Newsdesk
NeuroMetrix has been granted European Patent Number EP3538202 for its novel unbalanced biphasic waveform and electrode arrangement in transcutaneous electrical nerve stimulation.
May 22, 2023 | 6:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeuroMetrix's granted European patent may lead to increased market opportunities and potential revenue growth.
The granted patent for NeuroMetrix's novel nerve stimulation technology may open up new market opportunities in Europe, leading to potential revenue growth. As the patent directly pertains to the company's product offerings, it is highly relevant and important for investors to consider.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100